• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

andrew.jarnicki@unimelb.edu.au

Credentials


Position
Honorary (Principal Fellow)
Department of Biochemistry and Pharmacology
Education
PhD
The University of Western Australia
Bachelors Degree (Honours)
Murdoch University

Dr Andrew Jarnicki

Honorary (Principal Fellow)
Department of Biochemistry and Pharmacology

68 Scholarly works
7 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Repurposing ivacaftor to attenuate LPS-induced acute lung injury: evidence from a non-cystic fibrosis model
    DOI: 10.3389/fphar.2026.1787276
  • 2025

    Journal article

    Priming mucosal pathogen-agnostic innate immunity with an intranasal TLR2/6 agonist in an aged population
    DOI: 10.1183/23120541.01044-2024
  • 2024

    Research contracts (non-grants)

    Aim: To Conduct a Fragment Screen Against a Protein Target and Perform an Initial NMR Method Development and Stability Assessment.
  • 2023

    Journal article

    Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational study
    DOI: 10.1183/23120541.00641-2021
  • 2023

    Journal article

    Cigarette smoke depletes alveolar macrophages and delays clearance of Legionella pneumophila
    DOI: 10.1152/ajplung.00268.2022
  • 2022

    Research contracts (non-grants)

    Providing Fundamental Data Regarding the Physicochemical and Biopharmaceutical Properties of the Compounds
  • 2018

    Research Contracts

    ANTICALINS: INHALABLE BIOLOGICALS FOR ASTHMA and PULMONARY FIBROSIS
Andrew Jarnicki

RECENT SCHOLARLY WORKS

  • 2023

    Journal article

    Gastrointestinal consequences of lipopolysaccharide-induced lung inflammation
    DOI: 10.1007/s00011-022-01657-0
  • 2022

    Journal article

    Vaccine strain affects seroconversion after influenza vaccination in COPD patients and healthy older people
    DOI: 10.1038/s41541-021-00422-4
  • 2022

    Journal article

    Adverse roles of mast cell chymase-1 in COPD
    DOI: 10.1183/13993003.01431-2021
  • 2022

    Journal article

    Ivacaftor Alters Macrophage and Lymphocyte Infiltration in the Lungs Following Lipopolysaccharide Exposure
    DOI: 10.1021/ACSPTSCI.2C00007
  • 2022

    Journal article

    Aim2 suppresses cigarette smoke-induced neutrophil recruitment, neutrophil caspase-1 activation and anti-Ly6G-mediated neutrophil depletion
    DOI: 10.1111/imcb.12537
  • 2022

    Conference Proceedings

    MicroRNA-21 promotes chronic obstructive pulmonary disease through a SATB1/S100A9/NF-κB axis

RECENT PROJECTS

  • 2020

    Research Contracts

    Examination of the Efficacy of INNA-X in Influenza-Challenged Aged Mice
  • 2018

    Research Contracts

    Analysis of the Effect of GHK-Cu on Blood-Derived Lymphocytes From COPD Patients Compared to Control Subjects.

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224